Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Industrials | 8.79% |
| 5 | Consumer Discretionary | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FVR
2901
FrontView REIT
FVR
$489M
| $1.41M | ﹤0.01% |
69,487
+6,878
| +11% | +$124K |
|
|
PAL
2902
Proficient Auto Logistics
PAL
$149M
| $1.4M | ﹤0.01% |
206,089
+24,835
| +14% | +$166K |
|
2903
Neumora Therapeutics
NMRA
$287M
| $1.4M | ﹤0.01% |
823,583
+307,401
| +60% | +$585K |
|
2904
Orange County Bancorp
OBT
$513M
| $1.39M | ﹤0.01% |
37,711
+4,922
| +15% | +$171K |
|
2905
Home Bancorp
HBCP
$550M
| $1.39M | ﹤0.01% |
20,236
+1,694
| +9% | +$109K |
|
2906
Luxfer Holdings
LXFR
$458M
| $1.38M | ﹤0.01% |
76,348
+4,527
| +6% | +$70.7K |
|
|
NAGE
2907
Niagen Bioscience
NAGE
$254M
| $1.38M | ﹤0.01% |
431,614
-15,745
| -4% | -$63.9K |
|
2908
Caribou Biosciences
CRBU
$176M
| $1.37M | ﹤0.01% |
775,809
+216,167
| +39% | +$427K |
|
|
CLYM
2909
Climb Bio
CLYM
$942M
| $1.36M | ﹤0.01% |
104,634
+82,583
| +375% | +$853K |
|
2910
TAT Technologies
TATT
$485M
| $1.36M | ﹤0.01% |
+28,245
| New | +$1.13M |
|
2911
Sagimet Biosciences
SGMT
$635M
| $1.36M | ﹤0.01% |
175,872
+160,872
| +1,072% | +$1.09M |
|
2912
Everspin Technologies
MRAM
$393M
| $1.36M | ﹤0.01% |
+56,103
| New | +$1.26M |
|
2913
Vanguard Industrials ETF
VIS
$8.15B
| $1.36M | ﹤0.01% |
3,763
-120
| -3% | -$40.7K |
|
2914
Quanterix
QTRX
$132M
| $1.34M | ﹤0.01% |
310,701
-35,212
| -10% | -$114K |
|
2915
Melco Resorts & Entertainment
MLCO
$2.08B
| $1.34M | ﹤0.01% |
253,864
-14,126
| -5% | -$78.9K |
|
2916
AlTi Global
ALTI
$473M
| $1.33M | ﹤0.01% |
369,491
+22,501
| +6% | +$77.8K |
|
2917
Falcon's Beyond
FBYD
$524M
| $1.32M | ﹤0.01% |
73,699
+27,273
| +59% | +$387K |
|
2918
Shattuck Labs
STTK
$793M
| $1.32M | ﹤0.01% |
189,899
+149,018
| +365% | +$929K |
|
2919
Immix Biopharma
IMMX
$969M
| $1.31M | ﹤0.01% |
127,256
+99,794
| +363% | +$926K |
|
2920
Greenlight Captial
GLRE
$507M
| $1.31M | ﹤0.01% |
80,991
+7,712
| +11% | +$133K |
|
|
WW
2921
WW International
WW
$160M
| $1.31M | ﹤0.01% |
81,710
+32,411
| +66% | +$433K |
|
|
ASIC
2922
Ategrity Specialty Insurance
ASIC
$1.26B
| $1.31M | ﹤0.01% |
54,310
+2,133
| +4% | +$43.7K |
|
2923
HighPeak Energy
HPK
$1.03B
| $1.3M | ﹤0.01% |
185,682
+4,861
| +3% | +$33.5K |
|
2924
Holley
HLLY
$364M
| $1.29M | ﹤0.01% |
506,770
-281
| -0.1% | -$797 |
|
2925
Monopar Therapeutics
MNPR
$747M
| $1.29M | ﹤0.01% |
13,953
+1,395
| +11% | +$86.4K |
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.